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Background: Quinocarcin is the simplest of the bioxal- 
mycin/naphthyridinomycin/tetrazomine/saf~amycir~ class 
of anti-tumor antibiotics, which damage DNA in a 
process that is inhibited by superoxide dismutase (SOD). 
The oxazolidine moiety of this class of anti-tumor anti- 
biotics undergoes a redox self-disproportionation reaction 
of the Cannizzaro type. The reaction is proposed to 
proceed via an intermediate carbon-centered radical, 
which then reduces molecular oxygen to give superoxide. 
We set out to determine whether the DNA-cleavage 
properties of these anti-tumor antibiotics could be 
retained in less complex analogs of quinocarcin. 
Results: A totally synthetic, water-soluble analog of 
quinocarcin has been prepared. This analog produced 
superoxide, but had considerably reduced ability to cleave 
supercoiled circular DNA compared to quinocarcin or 
tetrazomine.When conjugated to the DNA-binding mole- 
cule spermine, however, it cleaved DNA as effectively as 
quinocarcin at less than l/10 the concentration. A conju- 
gate with netropsin displayed selective cleavage around the 
sequence 5’-d(ATTT)-3’. Molecular modeling of the inter- 
action between the conjugate and DNA, together with the 
pattern of cleavage, indicates that a non-diffusable oxidant 
is involved in sequence-selective DNA cleavage. The 
spermine conjugate displayed weak antimicrobial activity 
Conclusions: Knowledge of the stereoelectronic 
requirements for superoxide production by quinocarcin 
has allowed us to design a structurally less complex 
analog which has many of the same physical properties, 
including water solubility, the ability to produce super- 
oxide and the ability to cleave DNA. Covalently attach- 
ing known DNA-binding molecules to this analog gave a 
compound that produced sequence-specific DNA 
damage. Our results suggest that a mechanism other than 
superoxide production can mediate I)NA damage by the 
netropsin conjugate. 
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Introduction 
It is widely recognized that many clinically significant 
anti-tumor antibiotics mediate oxygen-dependent cleav- 
age of the ribose-phosphate backbone of cellular DNA 
and RNA. An enormous array of structurally diverse 
interesting natural products, semi-synthetic and totally 
synthetic substances mediate oxidative strand scission of 
nucleic acids through three main families of reactions: (1) 
metal-mediated activation of O,, ultimately producing 
hydroxyl radical or other reactive oxygen species; (2) 
non-metal-dependent generation of reactive carbon radi- 
cals that mediate C-H abstraction from the deoxyribose 
backbone, followed by reaction of the resulting deoxy- 
ribosyl radical with molecular oxygen, culminating in 
strand scission; and (3) photolytic production of hydroxyl 
radical, which does not require metal participation for the 
DNA-cleavage event. A wide range of chemistry can be 
found in the metal-dependent family of DNA-damaging 
agents. For example, many readily oxidizable organic sub- 
stances, such as semi-quinone radical anions, thiols and 
ascorbate, can reduce molecular oxygen, resulting in the 
production of superoxide. Unfortunately, significant non- 
specific cytotoxicity is observed for many anti-tumor 
antibiotics that mediate redox cycling of molecular 
oxygen, since the reactive oxidizing species can be 
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produced both intracellularly as well as extracellularly and 
are typically freely diffusable. For example, superoxide 
radical anion is well documented to mediate DNA-strand 
breakage via dismutation to hydrogen peroxide followed 
by Fenton-mediated generation of the diffusable and 
highly reactive hydroxyl radical. It has long been the goal 
of chemists to devise predictable and, most importantly, 
selective molecular inhibitors of DNA replication in the 
rapidly dividing tumor cell. Therefore, methods that 
improve upon the intrinsic selectivity of drugs that 
produce reactive oxygen radical species causing non- 
specific oxidative damage to cellular macromolecules are 
highly desirable. 
Quinocarcin (compound 2; Fig. 1) is a natural secondary 
metabolite produced by Stveptomyces melanovinaceus and is 
the simplest member of the bioxalomycin/naphthy- 
ridinomycin/tetrazomine/saframycin class of anti-tumor/ 
antibiotic compounds [l]. Quinocarcin displays weak 
antimicrobial activity against Gram-negative organisms 
and, as the citrate salt, displays promising anti-tumor activ- 
ity against several cell lines derived from solid mammalian 
carcinomas, including St-4 (gastric carcinoma), Co-3 
(human colon carcinoma), human mammary carcinoma, 
M5076 (sarcoma) and B16 (melanoma), as well as P388 
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(leukemia) [2]. More recently, a natural product struc- 
turally related to quinocarcin, tetrazomine (compound 3; 
Fig. 1), was isolated from Sacckarotkrix rnutabilis. 
Preliminary anti-tumor/antimicrobial assays of this sub- 
stance indicate a similar spectrum of biological activity to 
that displayed by quinocarcin [3]. Additionally, however, 
tetrazomine shows good antimicrobial activity against both 
Gram-negative and Gram-positive organisms and activity 
against the P388 leukemia cell line in viva. Preliminary 
studies on the modes of action for these compounds dis- 
closed that quinocarcin blocks RNA synthesis in prefer- 
ence to DNA and protein synthesis in P388 leukemia cells 
[4]. In Bacilhs wbtih, quinocarcin inhibited [3H]-thymi- 
dine incorporation, suggesting that DNA polymerase 
might be the target of inhibition in that organism [S]. 
One of several potential ways in which these com- 
pounds can damage cells involves an oxygen-dependent 
mechanism. Superoxide production by quinocarcin was 
first reported by Tomita et al. [S] and a mechanistic 
explanation has now been offered (Fig. 1) [6,7]. Our 
interest in these compounds was stimulated by the 
observation that quinocarcin exhibited the capacity to 
cleave plasmid DNA in an 02-dependent reaction that 
was inhibited by the addition of oxygen-free-radical 
scavengers such as methanol, tert-butanol, a-tocopherol, 
superoxide dismutase (SOD) and catalase.We have pre- 
viously reported data that supports the hypothesis that 
the oxygen-dependent scission of DNA is intimately 
associated with the propensity of these substances to 
undergo disproportionation reactions of their oxazoli- 
dine ring which, under anaerobic conditions, leads to 
the redox products 22 and 23 (exemplified for com- 
pound 2, Fig. 1). However, under aerobic conditions, 
molecular oxygen is proposed to react with an inter- 
mediate carbon-centered radical (compounds 20 or 21) 
which, with participation of the adjacent non-bonded 
electron pair on the nitrogen atom, results in the subse- 
quent expulsion of a molar equivalent of superoxide [6] 
(exemplified in Fig. 2 for the conversion of compound 
24 + compound 19 + superoxide radical anion). 
Superoxide radical anion subsequently suffers 
Fenton/Haber-Weiss redox cycling ultimately produc- 
ing hydroxyl radical, which is well documented to 
mediate sequence-random DNA-strand breaks [8,9]. 
In an effort to elucidate the stereoelectronic control 
elements of this reaction, we previously reported the 
total synthesis and DNA-cleavage abilities for the tetra- 
cyclic analogs of quinocarcin 4 and 5 (Fig. 1) [lo]. 
Analog 4, which possesses the same relative stereo- 
chemical configuration as quinocarcin, produces super- 
oxide and damages plasmid DNA. On the other hand, 
the C-lla-epimer (5) is dormant under the same set of 
conditions (Table 1, entries 7 and 8). The stark differ- 
ence in reactivity between the closely related com- 
pounds 4 and 5 suggested the obligate requirement of a 
trans-antiperiplanar relationship between the non- 
bonded electron pair of the oxazolidine nitrogen atom 
and the adjacent methine hydrogen atom at C-4 for the 
redox disproportionation reaction. Unfortunately, com- 
pounds 4 and 5 are virtually insoluble in water resulting 
in very low aqueous concentrations, low pH ranges (7 
or less) and/or mixed alcohol/water solvent systems 
making further in vitro and in vivo studies with these 
systems limited. 
The stereochemical insights gained from the analog 
systems 4 and 5 and the water-soluble nature of 
quinocarcin, a zwitterionic amino acid, provided the 
basis for the design and synthesis of compound 1, 
reported herein. Based on the mechanistic studies already 
described on compounds 2-5, it was anticipated that 
compound 1 would share the capacity of compounds 2, 
3 and 4, spontaneously to undergo auto-redox dispro- 
portionation at or above pH 7 and mediate oxidative 
damage to DNA. In addition, the carboxyl moiety of 
compound 1 was envisioned to provide a site to cova- 
lently attach DNA-binding molecules such as spermine 
and netropsin for the targeted and sequence-selective 
2, Quinocarcin, DC-52 3, Tetrazomine 
Me0 
Me0 
Fig. 1. Structures of quinocarcin, tetrazomine and synthetic structural analogs. 
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Fig. 2. Proposed mechanism for the auto- 
redox disproportionation of quinocarcin. 
Under anaerobic conditions, the forma- 
tion of compounds 22 and 23 is 
observed. Under aerobic conditions, the 
production of superoxide is observed, 
resulting in Fenton/Haber-Weiss cycling 
and hydroxyl-radical-mediated damage 
to DNA. 
QlJlNOCARClNOL QUINOCARCINAMIDE 
manipulation of DNA cleavage. Here we describe the 
preparation of conjugates of compound 1 with netropsin 
(16) and spermine (17) and the DNA-cleavage 
chemistry of these molecules. 
Results and discussion 
Synthesis of a water-soluble quinocarcin analog (1) 
Compound 1 was synthesized as illustrated in Fig. 3.The 
starting material was the P-hydroxyethyl ester 6 obtained 
as a single diastereomer, as previously described [lo]. 
Saponification of 6 with lithium hydroxide produced the 
corresponding P-hydroxy acid. This material was carried 
on without purification by reaction with three equiva- 
lents of thionyl chloride in refluxing toluene which 
resulted in @elimination and acid-chloride formation. 
Table 1. Rates of superoxide production by quinocarcin, 
tetrazomine and analogs. 
Entry Substrate P” Rate (M s-l x 10-9) 
1 
2 
3 
4 
5 
6 
7a 
8a 
9 
1 (2 mM) 6 
1 (2 mM) 7 
1 (2 mM) 8 
1 (5 mM) 8 
2 (1 mM) 8 
3 (1 mM) 8 
4 (1 mM) 8 
5 (1 mM) 8 
20 mM phosphate 8 
buffer (control) 
0.21 
0.82 
0.99 
1.56 
2.18 
7.5 
0.82 
0.0 
0.0 
aReactions run in 5 % methanol (aq). All reactions measured 
the rate of reduction of nitroblue tetrazolium (NBT). 
The intermediate cr,P-unsaturated acid chloride was then 
reduced to allyhc alcohol 7 with sodium borohydride in 
42 % isolated yield from 6. Reaction of compound 7 with 
methanesulfonyl chloride and triethylamine followed by 
addition of 2-amino-2-methyl-1-propanol produced the 
corresponding allylic amine 8. The diastereoselective 
reduction of this material was achieved by reacting com- 
pound 8 with one equivalent of palladium chloride under 
one atmosphere of hydrogen affording compound 9a as a 
single diastereomer in 98 % yield.The relative stereochem- 
istry of compound 9a was determined unambiguously by 
reacting an aliquot of compound 9a with trimethyloxo- 
nium tetrafluoroborate, producing the N-methylamine 9b. 
Spectroscopic data for this material was compared to phys- 
ical data for the same substance prepared by a different 
synthetic route [lo]. Compound 9b is the synthetic pre- 
cursor to compound 4, for which a single crystal X-ray 
analysis was obtained [lo]. Closure of the C and D rings 
to form tetracyclic intermediate 11 was achieved by first 
oxidizing compound 9a to aldehyde 10. Subsequent treat- 
ment of compound 10 with lithium hydroxide in reflux- 
ing ethanol removed the oxazolidinone, furnishing 
compound 11 in 22 % isolated yield. Formation of com- 
pound 1 was accomplished by reacting compound 11 
with ethyl bromoacetate in the presence of sodium bicar- 
bonate. The target, compound 1, was obtained following 
saponification of ethylester 12 with lithium hydroxide. 
Preparation of conjugates of compound 1 with netropsin 
(16) and with spermine (17) 
Netropsin and other distamycin-like peptides are well rec- 
ognized to bind in the minor groove in AT-rich regions of 
DNA [11-13].The flat, slightly curved structures of these 
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f, 9 
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9a R, = H, R, = CH2OH 
Me,oBF& 9b: R, = Me, R, = CH20H 
10, R, = H, R, = CHO 
12, R = Et 
1, R-H 13 
Fig. 3. Preparation of the water-soluble 
quinocarcin analog 1. (a) LiOH (aq), 
ethanol (r.t.); (b) thionylchloride, toluene 
(reflux); (c) NaBH,, dichloro- 
methane/ethanol (-78 “C to r.t.), 42 % 
yield from 6; (d) methanesulfonylchlo- 
ride, triethylamine, dichloromethane 
(0 “C); (e) 2-amino-2-methyl-l-propanol, 
46 % yield from 7; (0 PdCI,, H, (1 atm) 
ethanol; (g) dimethylsulfoxide, oxa- 
lylchloride (-78 “C), 95 % yield from 8; 
(h) LiOH (aq), ethanol (reflux 24 h), 
22 % isolated yield; (i) ethylbromo- 
acetate, NaHCO,, DMF; (j) LiOH (aq), 
ethanol (r.t.), 65 % yield from 11; (k) 
p-nitrophenol, DCC, dichloromethane 
(0 “C to r.t.), 63 % yield. 
compounds, coupled with their positive charge, facilitates 
preferential binding in these regions of the minor groove 
[14]. A variety of DNA-cleaving compounds have been 
covalently attached to distamycin peptides in an effort to 
increase the affinity of these compounds for DNA, to give 
enhanced DNA cleavage. Such complexes include the 
highly studied distamycin and penta-N-methylpyrrole- 
carboxamide (P5) Fe/EDTA complexes [15-171. More 
recently, other DNA-cleaving compounds, including 
enediynes and other radical-forming moieties, have been 
successfully linked to these peptides, altering their capacity 
to damage DNA [l&19]. 
It is well known that polyamines such as spermidine and 
spermine are good DNA-binding molecules. These basic 
substances are protonated at physiological pH, enabling 
them to associate strongly with the negatively charged 
phosphodiester regions of DNA, and to engage in hydro- 
gen-bonding interactions in both the major and minor 
grooves [20,22].Thus, in addition to the netropsin conju- 
gate, we also chose to conjugate compound 1 to spermine. 
Conjugation of compound 1 to these DNA-binding 
molecules was carried out by first reacting compound 1 
with para-nitrophenol and dicyclohexyl carbodiimide 
(DCC) to afford the activated pnvu-nitrophenyl ester 13 
(Fig. 3). The dipeptide 14 (Fig. 4) was prepared as 
described by Bailer et al. [22] with minor modifications. 
Reaction of compound 14 with N,N-dimethylethylene- 
diamine, DCC and N-hydroxybenzotriazole (HOBT) 
afforded compound 15 in 98 % yield. Reduction of the 
nitro group by catalytic hydrogenolysis followed by 
17 
Fig. 4. Preparations of netropsin conju- 
gate 16 and spermine dimer 17. (a) 
N,N-dimethylethylenediamine, DCC, 
HOBT, DMF, 98 % yield; (b) 5 % palla- 
dium on carbon, H, (1 atm), DMF; (c) 
13 (1 eq), Et,N, DMF, 47 % yield from 
15; (d) spermine (0.5 eq), Et,N, DMF 
(4 YZ), 20 % isolated yield. 
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drug concentration (PM) - 
5 6 7 8 9 
PH 
Fig. 5. DNA cleavage by quinocarcin, tetrazomine and designed analogs of quinocarcin. (a) Effects of concentration on DNA cleavage 
for compounds 1, 2 and 3, and conjugates 16 and 17. (b) Effects of pH on DNA-cleavage (S) for compound 1 x 10 (+), quinocarcin (Cl) 
and tetrazomine (m). The cleavage of supercoiled circular DNA was detected by loading the reactions onto 1 % agarose gels containing 
0.4 pg ml-l ethidium bromide and running for 2 h at 55 V. The electrophoresis gels were immediately visualized on a UV trans- 
illuminator and photographed using black and white instant film (Polaroid T667). The measurements of the relative intensities of DNA 
bands were performed on the photographs using the Dell System 325 computer and Technology Resources Inc. image-processing soft- 
ware. The film used to photograph the gels was confirmed to have a linear response to the range of DNA quantities used. The mean 
number of single strand scissions (S) per supercoiled DNA substrate was calculated using the Poisson distribution. When only forms I 
and II are present, the equation simplifies to S = -In f,, where f, is the fraction of form I molecules from the densitometry data. In those 
cases where form III (linear) DNA was present, S was calculated from f, + f,, = [I-S(2h + 1)/2L] s’* where h is the distance between hits 
on opposite strands to produce a linear molecule (16 base pairs) and L is the total number of base pairs in @Xl 74 (5386 base pairs). 
The damage to DNA was the percent conversion of form I to form II plasmid DNA from the densitometry data. 
immediate reaction with compound 13 produced for compound 17 (‘H NMR and 13C NMR) is consis- 
netropsin conjugate 16 in 52 “/o yield after chromatogra- tent with the production of a single diastereomer, but a 
phy. Similarly, spermine dimer 17 was prepared by reac- rigorous stereochemical assignment could not be made. 
tion of two equivalents of compound 13 with spermine 
in dimethylformamide (DMF) at 4 “C. Compound 17 Reactions with supercoiled circular (@Xl 74) DNA 
probably exists as a mixture of diastereomers (one set of To study the effectiveness of these compounds as DNA- 
enantiomers plus the meso-compound) since compound cleaving agents, compounds 1, 2, 3 and the conjugates 
1 was prepared as a racemate.The physical data collected 16 and 17 were reacted under various conditions with 
Table 2. Effects of additives on DNA nicking for 1, 2, 3, 16 and 17. 
Entry Substrate Conditions % inhibition % enhancement 
1 1 (1 mM) + IO kg ml-l SOD 85 
2 1 (1 mM) + 100 ml-l catalase pg 65 
3a 1 (1 mM) + 0.1 mM H,O, 19 
4 2 (1 mM) + 10 kg ml-’ SOD 99 
5 2 (1 mM) + 100 ml-l catalase pg 83 
6" 2 (1 mM) + 0.1 ml? H,O, kg 143 
7 3 (1 mM) + 10 kg ml-’ SOD 94 
8 3 (1 mM) + 100 pg ml-’ catalase 54 
9a 3 (1 mM) + 0.1 mM H,O, 68 
10 16 (0.2 mM) + 10 ml-’ SOD kg 0 0 
11 16 (0.2 mM) + 100 ml-l catalase pg 3 
12" 16 (0.2 mM) + 0.1 mM H,O, 95 
13 17 (0.2 mM) + 10 ml-’ SOD kg 83 
14 17 (0.2 mM) + 100 ml-’ catalase I*g 32 
15a 17 (0.2 mM) + 0.1 mM H,O, 289 
All reactions run in 20 mM phosphate buffer (pH 8) at 37 “C. The DNA used was covalently closed circular supercoiled @Xl 74. 
a Values corrected for background cleavage due to H,O, by subtraction of control. 
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(a) 1 2 3 4 5 6 cb)l 2 3 4 5 6 
supercoiled circular DNA (@X174). Compound 1 was 
observed to cleave this DNA substrate (Fig. 5a), 
although quinocarcin and tetrazomine were consider- 
ably more effective at the same concentrations. From the 
data shown inTable 2, it appears likely that compound 1 
produces superoxide by the same mechanism proposed 
for quinocarcin and tetrazomine. DNA cleavage medi- 
ated by compound 1 is inhibited by the addition of 
SOD and catalase. As expected, the addition of hydrogen 
peroxide had a stimulatory effect on DNA cleavage 
mediated by compound 1. Compound 1 displays parallel 
pH trends for DNA damage and superoxide release (as 
shown by the reduction of nitroblue tetrazolium 
(NBT)) to both quinocarcin and tetrazomine (Fig. 5b 
and Table 1) 
As shown in Fig. 5a, covalently linking compound 1 to 
spermine (fortning dimer 17) resulted in more than a 
ten-fold increase in DNA-cleavage activity as compared 
to compound 1 alone.These data, and those illustrated in 
Fig. 6, suggest that this increase in activity renders corr- 
pound 17 as potent as quinocarcin or tetrazomine. As 
expected, DNA cleavage by compound 17 was inhibited 
by the addition of SOD and catalase (Table 2, entries 13 
and 14) and was enhanced by the addition of hydrogen 
peroxide (Table 2, entry 15). 
Fig. 5a also shows the different concentration profiles 
for DNA cleavage by these compounds. At low concen- 
trations (below 25 PM) a slow increase in DNA-cleav- 
age was observed for all compounds. For compounds 2, 
3 and 17, a marked increase in DNA damage occurs 
above 25 PM; for compound 1, this change occurs 
above 1000 p,M. The exception to this trend seems to 
be compound 16 which maintains a slow increase in 
DNA-cleavage activity over the entire concentration 
range. These data suggest that the preferred AT-rich 
regions of the DNA substrate might be saturated by 
compound 16 at low drug concentration, and thus 
Fig. 6. Cleavage of DNA by compound 1 
linked to DNA-binding molecules. (a) 
Compounds 1, 2 and 17 show random 
sequence cleavage while compound 16 
shows sequence specificity. Reactions of 
1, 2, 16 and 17 with 3’-32P-labeled, 
516.base-pair restriction fragment from 
pBR322. Lane 1, control; lane 2, 
200 PM quinocarcin (2); lane 3, 
200 PM 1; lane 4, 200 PM 17; lane 5, 
200 FM 16; lane 6, Maxam and Gilbert 
G reaction. (b) Cleavage by compound 
16 on individual strands of DNA. 
Reactions of 16 with 3’- or 5’-32P- 
labeled 516.base-pair restriction frag- 
ment. Lane 1, 3’.Maxam and Gilbert G 
+ A reaction; lane 2, 5’-Maxam and 
Gilbert G + A reaction; lane 3, 3’- 
Maxam and Gilbert G reaction; lane 4, 
5’-Maxam and Gilbert G reaction; lane 
5, 3Slabeled DNA + 200 )LM 16; lane 6, 
5’.labeled DNA + 200 FM 16. All reac- 
tions run in 10 mM phosphate buffer 
(pH 8) at 37 “C for 10 h. 
increasing the drug concentration only has a moderate 
effect. Further evidence for sequence-selective cleavage 
by compound 16 and characterization of the cleavage 
sites was obtained using 32P-end-labeled restriction 
fragments, the results of which are described below. 
Reactions with 32P-labeled restriction fragments 
A 516-base-pair restriction fragment from pBR322 was 
used for DNA-cleavage studies.The fragment was labeled 
at the 3’ end of one strand by linearizing the plasmid with 
restriction endonuclease EcoRI, then filling in the ends 
with DNA polymerase in the presence of w~~P-~ATP, 
followed by digestion with RsaI. The desired 3’-32P-end- 
labeled 516-base-pair fragment was subsequently gel- 
purified. Fig. 6a depicts the sequence-random nature of 
cleavage of this substrate mediated by quinocarcin (lane 
2). As previously shown using the supercoiled plasmid 
cleavage assay, quinocarcin is a significantly more efficient 
DNA-cleaving agent than compound 1 (lane 3). 
However, as can be seen in lanes 3 and 4 (Fig. 6a), cova- 
lent attachment of spermine to compound 1 (producing 
compound 17) causes a marked increase in cleavage activ- 
ity although there is no indication that this damage is 
sequence specific. The netropsin conjugate (16) does, 
however, exhibit a definite sequence-selective DNA 
cleavage pattern (Fig. 6a, lane 5). 
To fully elucidate the pattern of DNA damage exhibited 
by compound 16, the 526-base-pair substrate was labeled 
at the 5’ end of the strand complementary to the one 
labeled in the 3’-32P substrate. This allowed us to 
examine the cleavage activity on each individual strand 
of the double-stranded DNA fragment (Fig. 6b). Lanes 5 
and 6 (Fig. 6b) illustrate reactions of compound 16 with 
the 3’-32P-labeled and 5’-32P-labeled DNA respectively. 
The data from this experiment is summarized on the 
histograms in Fig. 7; the highest frequency of cleavage 
occurred around double-stranded DNA containing the 
sequence 5’-d(ATTT)-3’ (NMR NOESY experiments 
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Fig. 7. The selectivity of DNA cleavage 
by compound 16. (a) Histogram for Fig. 
6a, lane 5. (b) Histogram for Fig. 6b, 
lanes 5 and 6. Histograms were pre- 
pared by measurements of the relative 
intensities of DNA bands from the 
autoradiograms in Fig. 6 using the Dell 
System 325 computer and Technology 
Resources Inc. image-processing soft- 
ware. The length of the arrows approxi- 
mate the relative intensities of the bands 
by scanning densitometry. 
(a) 
(b) 
have revealed similar sequence specificity for distamycin 
A complexed with the double-stranded, self-comple- 
mentary dodecamer 5’-d(CGCAAATTTGCG)-3’ [23]). 
The actual sites of cleavage however, were two bases to 
the 3’ end of this four-base recognition site. There is also 
evidence from the histograms (highlighted in boxes, Fig. 
7), that in some cases, the drug may be able to bind in 
two orientations, which would also allow cleavage to 
occur two bases to the 3’ end of the 5’-d(AAAT)-3’ 
recognition sequence. Such an observation is not unex- 
pected since it has been shown that many of the dis- 
tamycin peptides actually bind in two orientations in the 
minor groove in a 1 :l or 2:l ratio of drug to DNA 
(23,241. It is also significant to note the apparent direc- 
tional preference for cleavage exhibited by compound 
16, since little or no cleavage was observed around 
3’-d(ATTT)-5’ sequences. 
Analysis of the data indicates that lesions caused by com- 
pound 16 do not necessarily occur on the complemen- 
tary DNA strands at proximal Watson-Crick base pairs. 
Proximal double-strand damage is observed in the case 
of the distamycin-Fe/EDTA affinity-cleaving agents 
[15-171. In these systems, the metal that mediates the 
Fenton-type production of hydroxyl radical is held prox- 
imal to the DNA as a consequence of being complexed 
to the EDTA moiety. If the redox-active oxazolidine 
portion of DNA-bound compound 16 is generating a 
(non-diffusable) proximal reactive oxidant, or a highly 
reactive diffusable oxidant (such as hydroxyl radical) one 
would expect cleavage to occur on one or both strands 
of the DNA in close proximity to the site where the 
drug is bound to the recognition sequence.Alternatively, 
if superoxide is the only initial species produced by 
bound drug, the superoxide molecule must diffuse away 
from the drug to interact with Fe(M) in solution to ini- 
tiate the Fenton/Haber-Weiss cycling of hydroxyl 
radical, which is a diffusable sequence-random DNA- 
damaging agent. In this GIW, sequence-randorn cleavage 
would be expected. The only non-random aspect of 
DNA cleavage would be a ‘footprint’ of the bound drug, 
and this would only be anticipated for a very tightly 
bound drug. 
Examination of the autoradiogram and histogram for 
compound 16 suggests that an alternative mode of DNA 
damage may be operating. One plausible explanation for 
the observed cleavage pattern would be that compound 
16 is also operating via a direct hydrogen atom abstraction 
mechanism. Superoxide production by this class of com- 
pounds is proposed to occur as a result of the attack of 
molecular oxygen on a carbon-centered radical (Fig. 2, 
compounds 20 or 21) derived from the auto-redox dis- 
proportionation of the oxazolidine ring or by exogenous 
reduction of compound 19 (Fig. 2) followed by expulsion 
of superoxide. It is therefore possible that proper orienta- 
tion of the drug, as dictated by the netropsin moiety, 
might position a drug-centered radical in the proper 
geometry to abstract a hydrogen atom from the phospho- 
ribose backbone. In the presence of oxygen, attack of the 
resulting radical in the phophoribose backbone would 
ultimately result in scission of the DNA. Experimental 
support for this hypothesis is presented in Table 2 (entries 
10 and 11) which shows that DNA damage caused by 
compound 16 is not readily inhibited by the addition of 
SOD and catalase.This situation is in marked contrast to 
quinocarcin (compound 2,Table 2, entries 4 and 5), tetra- 
zomine (compound 3, Table 2, entries 7 and 8), com- 
pound 1 (Table 2, entries 1 and 2) and compound 17 
(Table 2, entries 13 and 14) whose DNA-cleavage chem- 
istry all display sensitivity to SOD and catalase.These data 
strongly suggest the intermediacy of a superoxide-inde- 
pendent mechanism in the DNA cleavage exhibited by 
compound 16.An issue of further intrigue in the case of- 
compound 16, involves the exact mechanism for the one 
electron oxidation or reduction of the bound or unbound 
drug and the presentation of the radical species to the 
DNA substrate. Studies are in progress to shed light on 
these issues. 
Based on the observed DNA-cleavage chemistry of com- 
pound 16, we have considered whether it is possible fl-om 
a structural point of view for compound 16 to bind in 
the minor groove to a four-base recognition sequence 
and adopt the requisite geometry to abstract a hydrogen 
atorn two bases to the 3’ side. We attempted to answer 
this question with molecular modeling by docking 
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Fig. 8. Netropsin conjugate 16 bound to the double-stranded dodecamer 5’.d(CGCAAATTTGCG)-3’. (a) Space-filling model depicting 
the complex between compound 16 and DNA as manually docked to the 5’.d(ATTT)-3’ sequence in the minor groove and minimized. 
(b) Cylindrical bond model showing the 2.8-A distance between the proposed carbon-centered radical of compound 16 and the C-4’ 
hydrogen two base pairs from the 3’ end of the 5’.d(ATTT)-3’ sequence. Molecular mechanics were carried out using DRIEDINC 
force-field in the molecular modeling package BIOGRAF (Molecular Simulations, Inc.). The double-stranded dodecamer 
5’.d(CGCAAATTTGCG)-3’ was obtained from the Brookhaven Protein Data Bank. 
the ‘natural’ enantiomer of compound 16 into the dodec- 
amer 5’-d(CGCAAATTTGCG)-3’, which contains the 
S’-d(ATTT)-3’ sequence of interest [25]. By taking 
advantage of known hydrogen-bonding interactions 
exhibited by netropsin [25,26], we obtained the min- 
mized structure depicted in Fig. 8. It can be seen from 
this model, which involves contact with all four bases of 
the recognition site, that C-7 of the oxazolidine ring of 
compound 16 is oriented to fall within - 3 A of the C-4’ 
hydrogen atom of the deoxyribose ring two base pairs to 
the 3’ end of this sequence. Hydrogen atom abstraction 
from C-4’ by a radical, followed by reaction of the result- 
ing deoxyribosyl C-4’-radical with molecular oxygen, is 
well documented [27,28] to result in strand scission pro- 
ducing the corresponding 3’-phosphoglycolate moiety 
attached to the next base to the 5’-side. Cameron and 
Uhlenbeck [27] have shown that T4 polynucleotide 
kinase (T4 PNK) has 3’ phosphatase activity, and it is pos- 
sible to demonstrate whether an oxidatively cleaved DNA 
product is a 3’-phosphate. Reaction of the DNA-cleavage 
products with T4 PNK selectively removes the phosphate 
from the 3’-position, giving a band of slower mobility by 
polyacrylamide gel electrophoresis (PAGE) due to the 
removal of one negative charge; the alternative 3’-phos- 
phoglycolate product resulting from C-4’ hydrogen atom 
abstraction and reaction of the resultant radical with 
dio>rygen does not react with T4 PNK. In support of this, 
we have recently obtained preliminary data which sug- 
gests that there n~ay be a strong preference for C-4’ 
hydrogen atom abstraction for this cleavage reaction. 
Reaction of compound 16 with the 5’-32P-labeled 
restriction fragment gave DNA products that, upon reac- 
tion with T4 PNK, resulted in no apparent band shift 
(data not shown) suggesting that the 3’-phosphoglycolate 
product may be formed preferentially (as predicted by the 
model in Fig. 8) in these reactions. 
Quinocarcin and tetrazomine both give a mixture of 
3’-phosphate and 3’-phosphoglycolate cleavage products, 
primarily resulting from non-specific hydrogen atom 
abstraction on the deoxyribosyl backbone by a diffusable 
oxidant, such as hydroxyl radical [7]. The 3’-phosphate 
products from these cleavage reactions gives the expected 
band shift to a slower-moving band on PAGE. For 
quinocarcin, the ratio of 3’-phosphate to 3’-phospho- 
glycolate was determined to be -6:4; for tetrazomine, the 
ratio was -8:2; and for Fe(II)/EDTA, the ratio was -4:6. 
These observations, coupled with the unexpected cleav- 
age chemistry exhibited by compound 16, suggest that 
there are likely to be multiple modes for the presentation 
of the DNA-damaging species to DNA. Efforts are under 
way to clarify these mechanistic questions and to improve 
upon the selectivity of the drug-nucleic acid interaction. 
Antimicrobial activity 
The new, synthetic compounds (1,16 and 17) were assayed 
for in vitro antibacterial activity against the following 
organisms by the agar disc-diffusion assay: B. subtilis, 
Staphylococcus au~eus, Micwcoccur luteus, Es&vi&a coli, 
Pseudomonas aenginosa, Klrbsiella pneumoniae, Servatia 
marzescens, Candida albicans, Sacchavomyces cewvisiae, Myco- 
bacteria perqvinum, hfycobacteria smegmatis, Mycobacteriajhtui- 
turn and Mycobactevia chelonei. Compound 17 displayed 
marginal weak anti-microbial activity against B. sobtilis (at 
1 mg ml-‘) and M. smqqmatis (at IO mg m-‘). Control 
assays with spermine and compound 1 showed no activity 
against M. smqmatis (> IO mg m-l). The lack of antimicro- 
bial activity of these compounds, particularly compound 1, 
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is somewhat surprisin g in light of the close structural 
resemblance of these compounds to quinocarcin and tetra- 
zomine and their demonstrated ability to produce super- 
oxide and damage DNA. Studies are in progress to prepare 
the C-lla epimers of compounds 1 and 17, so that their 
cytotoxic properties can be compared to those of com- 
pounds 1 and 17, and to examine whether these substances 
can alkylate DNA in the absence of a redox manifold. 
Significance 
Many anti-tumor antibiotics mediate their effects 
by generating superoxide, which causes oxidative 
damage to DNA. This activity also damages 
healthy cells, resulting in the undesirable host cyto- 
toxicity of many anti-tumor drugs. Although 
quinocarcin exhibits very promising anti-tumor 
activity, it suffers from problems of non-specific 
cytotoxicity. It would thus be highly desirable to 
find ways to attenuate the production of these 
reactive intermediates, or to direct the activity of 
the drugs more specifically. 
We have demonstrated that it is possible to 
prepare a structurally less complex analog of 
quinocarcin which exhibits most of the physical 
properties associated with the parent compound. 
By covalently attaching known DNA-binding 
molecules to this analog, we have also demon- 
strated the ability to vary the mechanism and 
DNA-cleavage specificity of this class of anti- 
tumor antibiotics. Through the use of synthetic 
chemistry, we have been able to identify unique 
stereoelectronic control elements of the oxazoli- 
dine ring, which is the biologically-significant 
functional group responsible for the production of 
reactive oxidants that ultimately cause damage to 
nucleic acids. We have been able to prepare, for 
the first time, a totally synthetic analog of this 
class of compounds that has markedly different 
DNA-damaging chemistry from the natural prod- 
ucts or the other synthetic analogs. It should now 
be possible to apply the insights gained from this 
study to the semi-synthetic alteration of the 
natural products themselves, with the objective of 
decreasing their non-specific cytotoxicity and 
thereby increasing their potential efftcacy as 
chemotherapeutic agents. 
Materials and methods 
General procedure for reductions of nitroblue 
tetrazolium (NBT) 
Reactions were performed by addition of appropriate 
amounts of reagent stock solutions to an aerated solution of 
nitroblue tetrazolium (0.12 mM; Sigma) in 20 mM phosphate 
buffer (at the indicated pH) containing 1 S/o Triton Xl00 
detergent (USB) and the final volunles brought to 750 pl with 
deionized water. The optical absorbance was measured at 
25 “C over a 30 min period at 500 nm (Varian DMS 80 
UV/vis spectrophotometer) and the AOD was the average 
slope for the linear change in optical density over the reaction 
time. The rates for superoxide production were calculated by 
assuming that [O?] does not appreciably change over this time 
period and is in excess (zero order in oxygen). The rates 
(reported in Table 1) were calculated from the AOD measure- 
ments and based on a molar extinction coefficient (E,) of 
12 200 for the monoformazan product of NBT at 500 nm. 
Reactions of 1,2, 3, 16 and 17 with supercoiled circular 
DNA (@X 174) 
All DNA-cleavage reaction mixtures were made up by addition 
at 0 “C of appropriate amounts of reagent stock solutions (stock 
solution of 16 was prepared as the hydrochloride salt) to a stock 
solution of supercoiled circular DNA (@X174) containing 
0.5 pg DNA per reaction (77 PM base pairs final concentra- 
tion).The total volumes were brought to 10 ~1 with deionized 
water and 80 mM phosphate buffer (pH 8 unless otherwise indi- 
cated) to achieve a final concentration of 20 mM phosphate.The 
reaction mixtures were incubated at 37 “C for 4 h in tightly 
capped plastic Eppendorf tubes. Stock solutions for experiments 
including DNA were prepared using sterile, distilled, deionized 
water and commercially available reagents: sodium phosphate 
monobasic (EM Science); sodium phosphate dibasic, 30 % 
hydrogen peroxide (Malinckrodt); superoxide dismutnse, beef 
liver catalase (suspension in water, from Boehringer Mannheim). 
Reactions of 1,2, 16 and 17 with j2P-labeled restriction 
fragments (pBR322) 
Reactions were made up by additions at 0 “C of appropriate 
amounts of reagent stock solutions (stock solution of 16 was 
prepared as the hydrochloride salt) to 3 (*l of 32P-labeled DNA 
(-100 FM base pairs final concentration).The total volume of 
the reactions was brought to 10 ~1 with deionized H,O and 
enough 80 mM phosphate buffer (pH 8) to achieve a final 
concentration of 10 mM phosphate. Each reaction was incu- 
bated at 37 “C for 10 h. To the reaction mixtures were then 
added 1 ~1 of 3M NaOAc (pH 5.2) and the reaction mixture 
was ethanol-precipitated and dried under reduced pressure.To 
each pellet was added 10 p,l of loading buffer (formamide, 
IO mM EDTA, pH 8,0.025 % xylenecyanol and 0.025 % bro- 
mophenol blue) then heated to 90 “C for 5 min and immed- 
iately loaded (10 000 cpm/lane as measured by a Packard 1500 
liquid scintillation analyzer) on a 20 x 40 cm, 15 % denaturing 
(urea) polyacrylamide gel containing 20 % formamide and run 
at 1300 V until the xylenecyanol had reached the bottom of 
the gel. The gels were then fixed in 5 ‘% acetic acid, 15 % 
methanol (aq), dried on a Bio-Rad 583 gel dryer and the 
bands visualized by autoradiography using Kodak X-OMAT 
AR (35 x 43 cm) film. 
Preparation of compounds 
Compounds were prepared by standard laboratory procedures 
as outlined in Figs 3 and 4. Chromatography for compound 
isolations employed Selectoscientific silica-gel (32-63) or EM 
Science thin layer chromatography plates (silica gel 60, F254, 
20 x 20 cm x 250 pm). ‘H NMR and 13C NMR data were 
collected using a Bruker AC-300 spectrometer and infrared 
spectral data were collected on a Perkin Elmer 1600 FTIR. 
Supplementary material available 
Preparation procedures and physicochemical data for con- 
pounds 7-17, preparation and purification procedures for 
supercoiled plasmid DNA (pBR322) and procedures for 3’ and 
5’-32P-labeling of restriction fra_gments. 
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